Identification and Optimization of the First Highly Selective GLUT1 Inhibitor BAY‐876

Cited by (299)

Items 101–200 of 299

1. Erythroid glucose transport in health and disease
   Hélène Guizouarn, Benoit Allegrini · 2020 · Pflügers Archiv - European Journal of Physiology
2. The NLRP3 molecule influences the therapeutic effects of mesenchymal stem cells through Glut1-mediated energy metabolic reprogramming
   Jingrou Chen, Shu‐Juan Xie, Dongbo Qiu, Maosheng Xie, Mengye Wu, Xiaoping Li, Xiaoran Zhang, Qili Wu, Yi Xiong, Chang You Wu et al. · 2023 · Journal of Advanced Research
3. Manipulation of Glucose Availability to Boost Cancer Immunotherapies
   Federica Marchesi, Debora Vignali, Beatrice Manini, Alessandra Rigamonti, Paolo Monti · 2020 · Cancers
4. Plumbagin reduction by thioredoxin reductase 1 possesses synergy effects with GLUT1 inhibitor on KEAP1-mutant NSCLC cells
   Shibo Sun, Yue Zhang, Weiping Xu, Rui Yang, Yijia Yang, Jianli Guo, Qiang Ma, Kun Ma, Jie Zhang, Jianqiang Xu · 2021 · Biomedicine & Pharmacotherapy
5. Glucose Transporters Are Key Components of the Human Glucostat
   I. Caspi, Daniel M. Tremmel, Julian Pulecio, Da-Peng Yang, Dingyu Liu, Jielin Yan, J. Odorico, D. Huangfu · 2024 · Diabetes
6. GLUT1 inhibition by BAY-876 induces metabolic changes and cell death in human colorectal cancer cells
   Masato Hayashi, Keishi Nakamura, Shinichi Harada, Mariko Hori Tanaka, Akiko Kobayashi, Hiroto Saito, Toshikatsu Tsuji, Daisuke Yamamoto, Hideki Moriyama, Jun Kinoshita et al. · 2025 · BMC Cancer
7. Copper metal-organic framework-based multifaceted strategy for boosting cancer therapy via synergistic cuproptosis and disulfidptosis
   Zede Wu, Mengdan Gao, Qiuyu Li, Haibo Lan, Yinfei Zheng, Shuting Zheng, Meirong Hou, Yikai Xu, Zheyu Shen, Bingxia Zhao et al. · 2025 · Biomaterials
8. The in vitro effect of the diabetes-associated markers insulin, leptin and oxidative stress on cellular characteristics promoting breast cancer progression is GLUT1-dependent
   Cláudia Silva, Nelson Andrade, João Tiago Guimarães, Emília Patrício, Fátima Martel · 2021 · European Journal of Pharmacology
9. Synthesis of Indomorphan Pseudo‐Natural Product Inhibitors of Glucose Transporters GLUT‐1 and ‐3
   Javier Ceballos, Melanie Schwalfenberg, George Karageorgis, Elena S. Reckzeh, Sonja Sievers, Claude Ostermann, Axel Pahl, Magnus Sellstedt, Jessica Nowacki, Marjorie A. Carnero Corrales et al. · 2019 · Angewandte Chemie
10. Epigenetic loss of the endoplasmic reticulum–associated degradation inhibitor SVIP induces cancer cell metabolic reprogramming
    Pere Llinàs‐Arias, Margalida Rosselló-Tortella, Paula López-Serra, Montserrat Pérez-Salvia, Fernando Setién, Silvia Marín, Juan Pablo Muñoz, Alexandra Junza, Jordi Capellades, María Eréndira Calleja-Cervantes et al. · 2019 · JCI Insight
11. The Role of Metabolic Plasticity in Blood and Brain Stem Cell Pathophysiology
    Catherine J. Libby, Jonathan McConathy, Victor M. Darley-Usmar, Anita B. Hjelmeland · 2019 · Cancer Research
12. Targeting Nutrient Dependency in Cancer Treatment
    Kexin Fan, Zhan Liu, Min Gao, Kangsheng Tu, Qiuran Xu, Yilei Zhang · 2022 · Frontiers in Oncology
13. The interplay between the tumor microenvironment and tumor-derived small extracellular vesicles in cancer development and therapeutic response
    Xuanyu Guo, Jiajun Song, Miao Liu, Xinyi Ou, Yongcan Guo · 2024 · Cancer Biology & Therapy
14. Recent Progress in the Development of Glucose Transporter (GLUT) Inhibitors
    Yuxuan Wang, Zhiqiang Sun, Zean Zhao, Jianxin Pang, Jianjun Chen · 2025 · Journal of Medicinal Chemistry
15. GLUT-1/PKM2 loop dysregulation in patients with non-ST-segment elevation myocardial infarction promotes metainflammation
    Francesco Canonico, Daniela Pedicino, Anna Severino, Ramona Vinci, Davide Flego, Eugenia Pisano, Alessia d’Aiello, Pellegrino Ciampi, Myriana Ponzo, Alice Bonanni et al. · 2022 · Cardiovascular Research
16. Identification of a Small-Molecule Glucose Transporter Inhibitor, Glutipyran, That Inhibits Cancer Cell Growth
    Makoto Kawatani, Harumi Aono, Sayoko Hiranuma, Takeshi Shimizu, Makoto Muroi, Naoko Ogawa, Tomokazu Ohishi, Shun‐ichi Ohba, Manabu Kawada, Toshihiko Nogawa et al. · 2021 · ACS Chemical Biology
17. Glutor, a Glucose Transporter Inhibitor, Exerts Antineoplastic Action on Tumor Cells of Thymic Origin: Implication of Modulated Metabolism, Survival, Oxidative Stress, Mitochondrial Membrane Potential, pH Homeostasis, and Chemosensitivity
    Mithlesh Kumar Temre, Saveg Yadav, Yugal Goel, Shrish Kumar Pandey, Ajay Kumar, Sukh Mahendra Singh · 2022 · Frontiers in Oncology
18. Genetic evidence that uptake of the fluorescent analog 2NBDG occurs independently of known glucose transporters
    Lucas J. D’Souza, Stephen H. Wright, Deepta Bhattacharya · 2022 · PLoS ONE
19. Drugging cancer metabolism: Expectations vs. reality
    David C. Montrose, Lorenzo Galluzzi · 2019 · International review of cytology
20. Active-targeting long-acting protein-glycopolymer conjugates for selective cancer therapy
    Jiawei Sun, Jianwen Guo, Longshuai Zhang, Like Gong, Yuanzi Sun, Xuliang Deng, Weiping Gao · 2023 · Journal of Controlled Release
21. Therapeutic strategies targeting metabolic characteristics of cancer cells
    Rilan Bai, Ying Meng, Jiuwei Cui · 2023 · Critical Reviews in Oncology/Hematology
22. Characterization of an iPSC-based barrier model for blood-brain barrier investigations using the SBAD0201 stem cell line
    Burak Ozgür, Elena Puris, Andreas Brachner, Antje Appelt‐Menzel, Sabrina Oerter, Viktor Balzer, Mikkel R. Holst, Rasmus Folmann Christiansen, Kathrine Hyldig, Stephen Timothy Buckley et al. · 2023 · Fluids and Barriers of the CNS
23. Metabolically‐Driven Active Targeting of Magnetic Nanoparticles Functionalized with Glucuronic Acid to Glioblastoma: Application to MRI‐Tracked Magnetic Hyperthermia Therapy
    Carlos Caro, Jose María Páez-Muñoz, Manuel Pernía Leal, Marta Carayol, Mónica Feijoo‐Cuaresma, Maria Luisa García‐Martín · 2024 · Advanced Healthcare Materials
24. Metabolic Rewiring in Radiation Oncology Toward Improving the Therapeutic Ratio
    Marike W. van Gisbergen, Emma Zwilling, Ludwig Jerome Dubois · 2021 · Frontiers in Oncology
25. Lysosome-targeting chimeras enable targeted protein degradation
    Bozhao Li, Yanyan Li, J. Jillian Zhang, Siren Badama, Xian Zhao, Liping Wang, Tian Wei Zhang, Xueting Wang, Xiaoqing Yi, Guo‐Bin Ding et al. · 2026 · Cell chemical biology
26. Respiration supports intraphagosomal filamentation and escape of Candida albicans from macrophages
    Nicola T. Case, Johannes Westman, Michael T. Hallett, Jonathan D. Plumb, Aiman Farheen, Michelle E. Maxson, Jessie MacAlpine, Sean D. Liston, Bernhard Hube, Nicole Robbins et al. · 2023 · mBio
27. A GLUT1 inhibitor-based fluorogenic probe for Warburg effect-targeted drug screening and diagnostic imaging of hyperglycolytic cancers
    Shunjie Zhang, Xinyu Wang, Ru Zhang, Yujun Cui, Heming Zhang, Weijie Song, Xiaohan Hou, Shibo Fu, Qingzhi Gao, Shengnan Liu · 2021 · Analytica Chimica Acta
28. Polychlorinated biphenyl quinone exposure promotes breast cancer aerobic glycolysis: An in vitro and in vivo examination
    Qi Qin, Bingwei V. Yang, Jing Liu, Erqun Song, Yang Song · 2021 · Journal of Hazardous Materials
29. New Developments in T Cell Immunometabolism and Therapeutic Implications for Type 1 Diabetes
    Mengdi Zhang, Yanyan Zhou, Zhiguo Xie, Shuoming Luo, Zhiguang Zhou, Jiaqi Huang, Bin Zhao · 2022 · Frontiers in Endocrinology
30. Functional importance of glucose transporters and chromatin epigenetic factors in Glioblastoma Multiforme (GBM): possible therapeutics
    Sahiti Chamarthy, Mekala Janaki Ramaiah · 2023 · Metabolic Brain Disease
31. Unveiling tumor immune evasion mechanisms: abnormal expression of transporters on immune cells in the tumor microenvironment
    Lu Chen, Yuchen Wang, Qingqing Hu, Yuxi Liu, Xuchen Qi, Zhihua Tang, Haihong Hu, Nengming Lin, Su Zeng, Lushan Yu · 2023 · Frontiers in Immunology
32. Therapeutic implications of the metabolic changes associated with BRAF inhibition in melanoma
    Alexander W. Loftus, Mehrdad Zarei, Hanna H. Kakish, Omid Hajihassani, Jonathan J. Hue, Christina S. Boutros, Hallie J. Graor, Faith Nakazzi, Tsegaw Bahlibi, Jordan Michael Winter et al. · 2024 · Cancer Treatment Reviews
33. Ligand-based design of GLUT inhibitors as potential antitumor agents
    Suliman A. Almahmoud, Wei Jin, Liying Geng, Jing Wang, Xiaofang Wang, Jonathan L. Vennerstrom, Haizhen A. Zhong · 2020 · Bioorganic & Medicinal Chemistry
34. Targeting ribosomal G-quadruplexes with naphthalene-diimides as RNA polymerase I inhibitors for colorectal cancer treatment
    Victoria Sánchez-Martín, David Alan Schneider, Matilde Ortiz-González, Ana Soriano‐Lerma, Ángel Linde-Rodríguez, Virginia Pérez‐Carrasco, José Gutiérrez Fernández, Marta Cuadros, Juan Carlos Morales, Carlos González et al. · 2021 · Cell chemical biology
35. Glucose metabolism controls monocyte homeostasis and migration but has no impact on atherosclerosis development in mice
    Alexandre Gallerand, Bastien Dolfi, Marion I. Stunault, Zakariya Caillot, Alexia Castiglione, Axelle Strazzulla, Chuqiao Chen, Gyu Seong Heo, Hannah P. Luehmann, Flora Batoul et al. · 2024 · Nature Communications
36. Coordinated modulation of glucose metabolism and immunity via metal-drug nanovesicles for hepatocellular carcinoma therapy
    Mengjie Kong, Liyan Qiu · 2025 · Journal of Controlled Release
37. SLC2A1+ tumour-associated macrophages spatially control CD8+ T cell function and drive resistance to immunotherapy in non-small-cell lung cancer
    Lei Wang, Han Chu, Degao Chen, Yuxuan Wei, Jia Jia, Liqi Li, Linfeng He, Lina Peng, Fangfang Liu, Shanshan Huang et al. · 2026 · Nature Cell Biology
38. Inhibition of Carbohydrate Metabolism Potentiated by the Therapeutic Effects of Oxidative Phosphorylation Inhibitors in Colon Cancer Cells
    Lichao Guo, Baochen Zhang, Wen Zhang, Yanqi Xie, Xi Chen, Xueke Sun, David S. Watt, Chunming Liu, H. Peter Spielmann, Xifu Liu · 2024 · Cancers
39. Mitochondrial metabolism: powering new directions in acute myeloid leukemia
    Ryan J. Stubbins, Irina A. Maksakova, David Sanford, A. MAUREEN ROUHI, Florian C. Kuchenbauer · 2021 · Leukemia & lymphoma/Leukemia and lymphoma
40. Design and synthesis of the ring-opened derivative of 3-n-butylphthalide-ferulic acid-glucose trihybrids as potential anti-ischemic agents
    Jianbing Wu, Wei Yin, Yinqiu Zhang, Hui Ye, Yunman Li, Jide Tian, Zhangjian Huang, Yihua Zhang · 2020 · Chinese Chemical Letters
41. NMS-873 functions as a dual inhibitor of mitochondrial oxidative phosphorylation
    Miranda F. Bouwer, Kathryn E. Hamilton, Patrick B. Jonker, Sam R. Kuiper, Larry L. Louters, Brendan D. Looyenga · 2021 · Biochimie
42. Exploiting Cysteine Residues of SLC Membrane Transporters as Targets for Drugs
    Mariafrancesca Scalise, Lara Console, Michele Galluccio, Lorena Pochini, Annamaria Tonazzi, Nicola Giangregorio, Cesare Indiveri · 2019 · SLAS DISCOVERY
43. Biologically produced and metal-organic framework delivered dual-cut CRISPR/Cas9 system for efficient gene editing and sensitized cancer therapy
    Jiantao Yu, Mao Tang, Zhengdong Zhou, Zixiang Wei, Feiyan Wan, Shengxin Hou, Qing Li, Yan Li, Leilei Tian · 2024 · Acta Biomaterialia
44. Endocytic vesicles act as vehicles for glucose uptake in response to growth factor stimulation
    Ryouhei Tsutsumi, Beatrix M. Ueberheide, Feng‐Xia Liang, Benjamin G. Neel, Ryuichi Sakai, Yoshiro Saito · 2024 · Nature Communications
45. Tryptophan deficiency induced by indoleamine 2,3‐dioxygenase 1 results in glucose transporter 1‐dependent promotion of aerobic glycolysis in pancreatic cancer
    Heng Liang, Jiani Zhan, Yunqiu Chen, Zikang Xing, Zhen Ning Tony He, Yuying Liu, Xuewen Li, Yijia Chen, Zhiyao Li, Chunxiang Kuang et al. · 2024 · MedComm
46. A Potential Neurotoxic Mechanism: Bisphenol S-Induced Inhibition of Glucose Transporter 1 Leads to ATP Excitotoxicity in the Zebrafish Brain
    Weiwei Wang, Ze Li, Shipeng Yuan, Zehui Du, Jiali Li, Hongyuan Peng, Shaoguo Ru · 2024 · Environmental Science & Technology
47. GLUT1-mediated glycolysis supports GnRH-induced secretion of luteinizing hormone from female gonadotropes
    Dequina Nicholas, Vashti S Knight, Karen J. Tonsfeldt, Tomohiro Terasaka, Olivia Molinar‐Inglis, Shannon B. Z. Stephens, JoAnn Trejo, Alexander S. Kauffman, Pamela L. Mellon, Mark A. Lawson · 2020 · Scientific Reports
48. Effect of oocyte vitrification on glucose transport in mouse metaphase II oocytes
    Yufei Wang, Haoya Chang, Qifu He, Yaxing Xue, Kang Zhang, Jian Kang, Ying Wang, Zhiming Xu, Yong Zhang, Fusheng Quan · 2021 · Reproduction
49. Dynamic glucose uptake, storage, and release by human microvascular endothelial cells
    Samaneh Yazdani, Philip J. Bilan, Javier R. Jaldín‐Fincati, Janice Pang, Felicia Ceban, Ekambir Saran, John Hunter Brumell, Spencer A. Freeman, Amira Klip · 2022 · Molecular Biology of the Cell
50. Iron promotes glycolysis to drive colon tumorigenesis
    Zhaoli Liu, Luke Villareal, Lavanya Goodla, Hyeoncheol Kim, Daniel M. Falcon, Mohammad Haneef, David R Martin, Li Zhang, Ho‐Joon Lee, Daniel M. Kremer et al. · 2023 · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
51. Insights into Substrate and Inhibitor Selectivity among Human GLUT Transporters through Comparative Modeling and Molecular Docking
    Rafaela Salgado Ferreira, Jean-Luc Pons, Gilles Labesse · 2019 · ACS Omega
52. Macrophage Origin, Metabolic Reprogramming and IL-1β Signaling: Promises and Pitfalls in Lung Cancer
    Emma Guilbaud, Emmanuel L. Gautier, Laurent Yvan‐Charvet · 2019 · Cancers
53. Different Glucose Metabolic Features According to Cancer and Immune Cells in the Tumor Microenvironment
    Hongyoon Choi, Kwon Joong Na · 2021 · Frontiers in Oncology
54. Grp78 is required for intestinal Kras-dependent glycolysis proliferation and adenomagenesis
    Claudia N. Spaan, Ruben J. de Boer, Wouter L. Smit, Jonathan H. M. van der Meer, Manon van Roest, Jacqueline L.M. Vermeulen, Pim J. Koelink, Marte A. J. Becker, Simei Go, Joana Silva et al. · 2023 · Life Science Alliance
55. Recent advances in nanomedicine for metabolism-targeted cancer therapy
    Jun Da, Xinjia Di, Yuqi Xie, Jili Li, Lili Zhang, Yanlan Liu · 2024 · Chemical Communications
56. Advancing drug discovery through assay development: a survey of tool compounds within the human solute carrier superfamily
    Daniela Digles, Álvaro Inglés‐Prieto, Vojtech Dvorak, Tamara A. M. Mocking, Ulrich Goldmann, Andrea Garofoli, Evert J. Homan, Alberto di Silvio, Lucia Azzollini, Francesca Sassone et al. · 2024 · Frontiers in Pharmacology
57. Metabolic dysfunction mediated by HIF-1α contributes to epithelial differentiation defects in eosinophilic esophagitis
    Sinead M. Ryan, Louise Crowe, Sofía N Almeida Cruz, Matthew D. Galbraith, Carol O’Brien, Juliet A Hammer, Ronan Bergin, Shauna K Kellett, Gary E. Markey, Taylor M Benson et al. · 2024 · Journal of Allergy and Clinical Immunology
58. Exploring the impact of mitochondrial-targeting anthelmintic agents with GLUT1 inhibitor BAY-876 on breast cancer cell metabolism
    Tanner J. Schumacher, Ananth V. Iyer, Jon N. Rumbley, Conor T. Ronayne, Venkatram R. Mereddy · 2024 · BMC Cancer
59. BAG6 contributes to glucose uptake by supporting the cell surface translocation of the glucose transporter GLUT4
    Setsuya Minami, Naoto Yokota, Hiroyuki Kawahara · 2020 · Biology Open
60. Knockout of syntaxin-4 in 3T3-L1 adipocytes reveals new insight into GLUT4 trafficking and adiponectin secretion
    Hannah L. Black, Rachel Livingstone, Cynthia Corley Mastick, Mohammed Al Tobi, Holly Taylor, Angéline Geiser, Laura Stirrat, Dimitrios Kioumourtzoglou, John R. Petrie, James G. Boyle et al. · 2021 · Journal of Cell Science
61. Effects of PTH on osteoblast bioenergetics in response to glucose
    Victoria DeMambro, Tian Li, Vivin Karthik, Clifford james Rosen, Anyonya R. Guntur · 2023 · Bone Reports
62. Inhibition of mitochondrial fusion via SIRT1/PDK2/PARL axis breaks mitochondrial metabolic plasticity and sensitizes cancer cells to glucose restriction therapy
    Yongjian Guo, Chengju Luo, Yuening Sun, Wenjing Guo, Ruitian Zhang, Xin Zhang, Xue Ke, Libin Wei · 2023 · Biomedicine & Pharmacotherapy
63. MGAT4A/Galectin9‐Driven N ‐Glycosylation Aberration as a Promoting Mechanism for Poor Prognosis of Endometrial Cancer with TP53 Mutation
    Zhen Yuan Zhu, Jingya Sun, Weiqing Xu, Qinghe Zeng, Hanyi Feng, Lijuan Zang, Yinyan He, Xiao Hong He, Na Sheng, Xuelian Ren et al. · 2024 · Advanced Science
64. Discovery of New Glucose Uptake Inhibitors as Potential Anticancer Agents by Non-Radioactive Cell-Based Assays
    Hsueh-Chih Hung, Licheng Li, Jih‐Hwa Guh, Fan‐Lu Kung, Lih‐Ching Hsu · 2022 · Molecules
65. Muscle-Specific Ablation of Glucose Transporter 1 (GLUT1) Does Not Impair Basal or Overload-Stimulated Skeletal Muscle Glucose Uptake
    Shawna L. McMillin, Parker L. Evans, William M. Taylor, Luke A. Weyrauch, Tyler J. Sermersheim, Steven S. Welc, Monique R. Heitmeier, Richard C. Hresko, Paul W. Hruz, Françoise Koumanov et al. · 2022 · Biomolecules
66. Anti-Glycolytic Drugs in the Treatment of Hepatocellular Carcinoma: Systemic and Locoregional Options
    Milad Pourbaghi Masouleh, Leila Haghani, Ken Zhao, Anita Karimi, Brett S. Marinelli, Joseph Patrick Erinjeri, Jean‐Francois Henri Geschwind, Hooman Yarmohammadi · 2023 · Current Oncology
67. Current Approaches in Diabetes Treatment and Other Strategies to Reach Normoglycemia
    Worood Sirhan, Ron Piran · 2020 · Current Topics in Medicinal Chemistry
68. Carbohydrate effect of novel arene Ru(II) phenanthroline-glycoconjugates on metastatic biological processes
    Elena de la Torre‐Rubio, Laura Muñoz‐Moreno, Ana Maria Bajo, M.S. Arias, Tomás Cuenca, Lourdes Gude, Eva Royo · 2023 · Journal of Inorganic Biochemistry
69. Exploring metabolic reprogramming in esophageal cancer: the role of key enzymes in glucose, amino acid, and nucleotide pathways and targeted therapies
    Xue-Man Dong, Lin Chen, Yu-Xin Xu, Pu Wu, Tian Xie, Zhaoqian Liu · 2025 · Cancer Gene Therapy
70. Metabolism, a Blossoming Target for Small-Molecule Anticancer Drugs
    Michela Puxeddu, Romano Silvestri, Giuseppe La Regina · 2025 · Molecules
71. Isosteres of ester derived glucose uptake inhibitors
    Dennis A. Roberts, Liyi Wang, Weihe Zhang, Yi Liu, Pratik Shriwas, Yanrong Qian, Xiaozhuo Chen, Stephen C. Bergmeier · 2020 · Bioorganic & Medicinal Chemistry Letters
72. A GLUT1 inhibitor-based probe significantly ameliorates the sensitivity of tumor detection and diagnostic imaging
    Shengnan Liu, Weijie Song, Yujun Cui, Ziru Sun, Zhenhua Huang, Qingzhi Gao · 2021 · Chemical Communications
73. Identification of the Highly Active, Species Cross-Reactive Complex I Inhibitor BAY-179
    Jeffrey Mowat, Alexander Ehrmann, Sven Christian, Carolyn Sperl, Stephan Menz, Judith Günther, Roman Christian Hillig, Marcus Bauser, Wolfgang Schwede · 2022 · ACS Medicinal Chemistry Letters
74. Overexpression of facilitative glucose transporter-3 and membrane procoagulation in maternal platelets of preeclamptic pregnancy
    Ejaife O. Agbani, Lorraine Chow, Joshua Nicholas, Leslie Skeith, Prism Schneider, Alexander J. Gregory, Etienne Mahé, Lisa Yamaura, Daniel W Young, Antoine Dufour et al. · 2023 · Journal of Thrombosis and Haemostasis
75. GLUT1 contributes to impaired epithelial tight junction in the late phase of acute lung injury
    Haixiong Tang, Zemin Chen, Sudan Gan, Yan Liang, Hailing Zhang, Changyun Yang, Liqin Lin, Yubiao Guo, Shiyue Li, Jing Li et al. · 2023 · European Journal of Pharmacology
76. GLUT1 Promotes NLRP3 Inflammasome Activation of Airway Epithelium in Lipopolysaccharide-Induced Acute Lung Injury
    Jiehong Li, Yijian Li, Guanjin Chen, Yan Liang, Jianpeng Xie, Shuiying Zhang, Kai Zhong, Tong Jiang, Haisu Yi, Haixiong Tang et al. · 2024 · American Journal Of Pathology
77. TFE3–SLC36A1 axis promotes resistance to glucose starvation in kidney cancer cells
    Suli Lv, Zongbiao Zhang, Zhenyong Li, Ke Qian, Xianyun Ma, Neng Li, Xuefeng Zhao, Qingli Zou, Lidong Sun, Tanjing Song · 2024 · Journal of Biological Chemistry
78. Identification of novel inhibitors of GLUT1 by virtual screening and cell-based assays
    Xiaotong Chen, Yunshuo Zhao, Sifan Lyu, Guanfei Gao, Yanfeng Gao, Yuanming Qi, Jiangfeng Du · 2021 · Investigational New Drugs
79. Human red blood cell uptake and sequestration of arsenite and selenite: Evidence of seleno-bis(S-glutathionyl) arsinium ion formation in human cells
    Gurnit Kaur, Warda Javed, Olena Ponomarenko, Kamran Shekh, Diane P. Swanlund, Janet R. Zhou, Kelly L. Summers, Angela Casini, Margot N. Wenzel, Joseph R. Casey et al. · 2020 · Biochemical Pharmacology
80. The Landscape of Cancer Metabolism as a Therapeutic Target
    Kenji Ohshima · 2025 · Pathology International
81. Fluid shear stress activates a targetable mechano-metastatic cascade to promote medulloblastoma metastasis
    Hyun-Kee Min, Hongyu Zhao, Alexander T. Bahcheli, Peng Pan, Jade Chan, Junsheng Chen, Esther Low, Yuxiao Zhou, Xian Wang, Savo Bajic et al. · 2025 · Nature Biomedical Engineering
82. Nanomedicine strategies for disulfidptosis activation in SLC7A11-high tumors
    Zhanzheng Ye, Yinsha Yao, Yitianhe Xu, Jinyao Ye, Qing Yao, Longfa Kou, Ruijie Chen · 2025 · Colloids and Surfaces B Biointerfaces
83. Comparative analysis of senolytic drugs reveals mitochondrial determinants of efficacy and resistance
    Wakita, Masahiro, Ito, Koyu, Fujii, Kaho, Sakamoto, Dai, Mikawa, Takumi, Sugawara, Sho, Zhou, Xiangyu, Park, Jeong Hoon, Miyagawa, Hideka, Motooka, Daisuke et al. · 2026 · Nature Aging
84. Epithelial–Mesenchymal Transition Suppresses AMPK and Sensitizes Cancer Cells to Pyroptosis under Energy Stress
    Mingwei Liang, Jennifer W. Li, Huacheng Luo, Sarah Lulu, Ozlem Calbay, Anitha Kota Shenoy, Ming Tan, Brian Keith Law, Shuang Huang, Tsan Sam Xiao et al. · 2022 · Cells
85. Effects of d-ribose on human erythrocytes: Non-enzymatic glycation of hemoglobin, eryptosis, oxidative stress and energy metabolism
    Zehong Zhang, Yu Tai, Zhi Liu, Yunxia Pu, Liang An, Xiaojing Li, Lili Li, Yaqi Wang, Zhongbin Yang, Chao Duan et al. · 2023 · Blood Cells Molecules and Diseases
86. RETRACTED: Enhanced chemotherapeutic efficacy of docetaxel in human lung cancer cell line via GLUT1 inhibitor
    Mona Bahremani, Nadereh Rashtchizadeh, Mehdi Sabzichi, Amir Mansour Vatankhah, Sepideh Danaiyan, Haniyeh Poursistany, Jamal Mohammadian, Amir Ghorbanihaghjo · 2023 · Journal of Biochemical and Molecular Toxicology · Retracted
87. Tanycytes release glucose using the glucose-6-phosphatase system during hypoglycemia to control hypothalamic energy balance
    María José Barahona, Luciano Ferrada, Matías Vera, Francisco Nualart · 2024 · Molecular Metabolism
88. Targeting metabolic pathway enhance CAR-T potency for solid tumor
    Wenying Li, Jiannan Chen, Zhigang Guo · 2024 · International Immunopharmacology
89. Metabolic adaptations to acute glucose uptake inhibition converge upon mitochondrial respiration for leukemia cell survival
    Monika Komza, Jesminara Khatun, Jesse D. Gelles, Andrew Paul Trotta, Ioana Abraham‐Enachescu, Juan Henao, Ahmed M. Elsaadi, Andriana G. Kotini, Cara Clementelli, Joann Arandela et al. · 2025 · Cell Communication and Signaling
90. Exposure of human immune cells, to the antiretrovirals efavirenz and lopinavir, leads to lower glucose uptake and altered bioenergetic cell profiles through interactions with SLC2A1
    Bethany J. Heaton, Rebecca L. Jensen, James Line, Christopher A. W. David, Danielle E. Brain, Amy E. Chadwick, Neill J. Liptrott · 2022 · Biomedicine & Pharmacotherapy
91. Dihydroceramide desaturase 1 ( DES1 ) promotes anchorage‐independent survival downstream of HER2 ‐driven glucose uptake and metabolism
    Ryan W. Linzer, Danielle L. Guida, Jonathan Aminov, Justin M. Snider, Gabrielle Khalife, A. Burak Buyukbayraktar, Charbel Alhaddad, Andrew E Resnick, Pule Wang, Chun‐Hao Pan et al. · 2022 · The FASEB Journal
92. Green synthesis of 2-trifluoromethylquinoline skeletons via organocatalytic N-[(α-trifluoromethyl)vinyl]isatins C N bond activation
    Cong‐Bin Ji, Ding-Xiong Xie, Mei Chen, Ye-Ying Lan, Baohua Zhang, Jiying Yang, Zhenghui Kang, Shujie Chen, Yu-Wei Zhang, Yun‐Lin Liu · 2024 · Chinese Chemical Letters
93. A Novel Multiple-Read Screen for Metabolically Active Compounds Based on a Genetically Encoded FRET Sensor for ATP
    Ziyan Zhao, Rahul Rajagopalan, Adam Zweifach · 2018 · SLAS DISCOVERY
94. GLUT1: a promising drug target for cancer treatment
    Xiaotong Chen, Yunshuo Zhao, Yanfeng Gao, Yuanming Qi, Jiangfeng Du · 2021 · Anti-Cancer Drugs
95. Co-expression and prognosis analyses of GLUT1–4 and RB1 in breast cancer
    Xiaodan Zhang, Xiaocong Pang, Zhuo Zhang, Qianxin Liu, Hanxu Zhang, Qian Xiang, Yimin Cui · 2021 · BMC Cancer
96. Targeting ribosomal G-quadruplexes with naphthalene-diimides as RNA polymerase I inhibitors for colorectal cancer treatment
    Victoria Sánchez-Martín, David Alan Schneider, Matilde Ortiz-González, Ana Soriano‐Lerma, Ángel Linde-Rodríguez, Virginia Pérez‐Carrasco, José Gutiérrez Fernández, Marta Cuadros, Juan Carlos Morales, Carlos González et al. · 2021 · Cell chemical biology
97. Glucose Transporter 1 Inhibitors Induce Autophagy and Synergize With Lenvatinib in Thyroid Cancer Cells
    Chi‐Yu Kuo, Yi‐Chiung Hsu, Ming‐Jen Chen, Chi‐Hsin Lin, Ying-Syuan Li, Shih‐Ping Cheng · 2024 · Head & Neck
98. Glyco Ionic Liquids as Novel Nanoparticle Coatings to Enhance Triple‐Negative Breast Cancer Drug Delivery
    Gaya S. Dasanayake, Christine M. Hamadani, Fikir Hailu, Iyanuoluwani J. Owolabi, Mira Patel, Claylee M. Chism, Veeresh B. Toragall, Sandeep Kumar Misra, Sushil K. Mishra, Mohamed E. Jahan et al. · 2025 · Advanced Healthcare Materials
99. Small molecule inhibitors for cancer metabolism: promising prospects to be explored
    Dan Liu, Hongping Wang, Xingxing Li, Jifang Liu, Yanling Zhang, Jing Ying Hu · 2023 · Journal of Cancer Research and Clinical Oncology
100. Small-molecule inhibitors of glucose transporters
     Makoto Kawatani, Hiroyuki Osada · 2024 · Vitamins and hormones